Sab Biotherapeutics Inc. SABS
$3.98
▼ -1.48% 24H
About
Sab Biotherapeutics Inc. is a biotechnology company dedicated to developing advanced immunotherapies through its innovative platform for producing polyclonal antibodies. The primary purpose of the company is to harness the power of the human immune system to treat and prevent a wide range of infectious diseases and imm…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees86
TickerSABS
Statistics
Market Cap$301.5M
Revenue (TTM)$0
Net Income$13.3M
Net Margin—
EPS$-0.79
P/E15.32
P/S—
P/B1.13
EV/EBITDA-2.85
ROE-0.3%
Dividend Yield—
Price$3.98
Data: Twelve Data · Revenue = mcap / P/S